AU2002212348A1 - Immortalized preosteoblasts and method for their production - Google Patents

Immortalized preosteoblasts and method for their production

Info

Publication number
AU2002212348A1
AU2002212348A1 AU2002212348A AU1234802A AU2002212348A1 AU 2002212348 A1 AU2002212348 A1 AU 2002212348A1 AU 2002212348 A AU2002212348 A AU 2002212348A AU 1234802 A AU1234802 A AU 1234802A AU 2002212348 A1 AU2002212348 A1 AU 2002212348A1
Authority
AU
Australia
Prior art keywords
osteoblasts
present
immortalized
preosteoblasts
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212348A
Other languages
English (en)
Inventor
Christian Darimont-Nicolau
Catherine Mace
Elizabeth Offord Cavin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2002212348A1 publication Critical patent/AU2002212348A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1264—DNA nucleotidylexotransferase (2.7.7.31), i.e. terminal nucleotidyl transferase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2002212348A 2000-10-27 2001-10-26 Immortalized preosteoblasts and method for their production Abandoned AU2002212348A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00123570A EP1207196A1 (de) 2000-10-27 2000-10-27 Immortalisierte pre-osteoblasten und verfahren zur deren herstellung
EP00123570.4 2000-10-27
PCT/EP2001/012441 WO2002034891A2 (en) 2000-10-27 2001-10-26 Immortalized preosteoblasts and method for their production

Publications (1)

Publication Number Publication Date
AU2002212348A1 true AU2002212348A1 (en) 2002-05-06

Family

ID=8170233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212348A Abandoned AU2002212348A1 (en) 2000-10-27 2001-10-26 Immortalized preosteoblasts and method for their production

Country Status (9)

Country Link
US (1) US7202082B2 (de)
EP (2) EP1207196A1 (de)
JP (1) JP4707304B2 (de)
CN (1) CN100595275C (de)
AT (1) ATE348879T1 (de)
AU (1) AU2002212348A1 (de)
DE (1) DE60125423T2 (de)
ES (1) ES2277951T3 (de)
WO (1) WO2002034891A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007041655A1 (de) * 2007-09-03 2009-03-05 Medicyte Gmbh Vermehrung von primären Zellen und deren Verwendung
EP2383334A4 (de) * 2009-01-23 2013-01-16 Univ Osaka Feederzelle für targetzelleninduktion
DE102014101862A1 (de) * 2014-02-14 2015-08-20 Eberhard Karls Universität Tübingen Medizinische Fakultät Immortalisierte Zelle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5681701A (en) * 1993-07-12 1997-10-28 Mayo Foundation For Medical Education And Research Immortalized human fetal osteoblastic cells
WO1995013383A1 (en) * 1993-11-12 1995-05-18 Geron Corporation Methods and reagents for lengthening telomeres
CA2320136A1 (en) * 1998-02-10 1999-08-12 Oregon Health Sciences University Treatment of bony defects with osteoblast precursor cells
US6399384B1 (en) * 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells

Also Published As

Publication number Publication date
EP1409652A2 (de) 2004-04-21
EP1409652B1 (de) 2006-12-20
EP1207196A1 (de) 2002-05-22
ES2277951T3 (es) 2007-08-01
CN1471576A (zh) 2004-01-28
US7202082B2 (en) 2007-04-10
CN100595275C (zh) 2010-03-24
WO2002034891A2 (en) 2002-05-02
JP4707304B2 (ja) 2011-06-22
US20030186438A1 (en) 2003-10-02
WO2002034891A3 (en) 2002-12-12
DE60125423D1 (de) 2007-02-01
ATE348879T1 (de) 2007-01-15
JP2004512042A (ja) 2004-04-22
DE60125423T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
EP1294855A4 (de) Methode zur kontrolle der differenzierung von embryonalen stammzellen (es-zellen) durch die kultivierung von es-zellen in anwesenheit antagonisten des bmp-2 weges
Thomas et al. Bone marrow stromal cells are load responsive in vitro
EP1471788A4 (de) Verfahren zur induzierung der differenzierung in stammzellen, verfahren zur erzeugung von gewebe mit von mikroorganen und stammzellen abgeleiteten gerüstmatrizes, verfahren zur herstellung adulter stammzellen und verfahren zur kontinuierlichen erzeugung von stammzellen mittels implantation von mikroorganen als quellen für stammzellen
HK1080115A1 (en) Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom e1-
MX2007001772A (es) Composiciones y metodos para auto-renovacion y diferenciacion de celulas troncales embrionicas humanas.
BRPI0414961A (pt) processo de indução da diferenciação de células tronco em células do miocárdio
GB2391065A (en) Classifying cells based on information contained in cell images
GB0614442D0 (en) Metabolically engineered cells for the production of pinosylvin
WO2004015077A3 (en) Compositions and methods for neural differentiation of embryonic stem cells
CA2442135A1 (en) Methods to culture circovirus
WO2005103716A3 (en) Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
AU2002356749A1 (en) Process for the production of polypeptides in mammalian cell cultures
AU4017501A (en) Cell culture spinner flasks
Morris et al. Mechanisms of fluid-flow-induced matrix production in bone tissue engineering
AU2002212348A1 (en) Immortalized preosteoblasts and method for their production
WO2003071861A3 (en) Vanillin biosynthetic pathway enzyme from vanilla planifolia
WO2008061804A3 (en) Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production
WO2003020896A3 (en) Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
ID26346A (id) PROSES PEMBUATAN TURUNAN ASAM 5-HIDROKSIBENZO (b)TIOFEN-3-KARBOKSILAT
EP1172436A4 (de) Ceramidasegen
ATE338798T1 (de) Chemielumineszierende reaktionen unter verwendung von dihydroxylierten aromaten und heterocyclischen enolphosphaten
Massas et al. Estrogen modulation of osteoblastic cell‐to‐cell communication
Lowe Golgi complex: biogenesis de novo?
AR018085A1 (es) Molecula polinucleotidica aislada; vector recombinante, celula hospedadora, producto genico avec, procedimiento para producirlo, procedimiento paraproducir un producto genico homologo, vector de reemplazo genico, vector recombinante, celula hospedadora streptomyces, procedimiento para identificarmut
Neeley et al. Osteogenesis in an in vitro coculture of human periodontal ligament fibroblasts and human microvascular endothelial cells